Avidi­cure's $50M seed round; Flag­ship's new AI com­pa­ny that de­tects dis­ease

Plus, news about No­vo Hold­ings, Biox­odes and Tem­pus AI:

Dutch biotech rais­es $50M in seed fund­ing: Avidi­cure, which is de­vel­op­ing avid­i­ty en­gi­neered an­ti­bod­ies for can­cer …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER